Dr. Chip Hodges

Jim Hugman knew he could find the prostate cancer care he needed right here at Texas Oncology Longview Cancer Center—experienced specialists and advanced technology, close to home.

Now he’s turning his journey into a message for others: Get screened.

Prostate cancer screening starts with a simple PSA blood test. Talk to your doctor about when it’s right for you.




Dr. Bill Taylor
Dr. Chip Hodges

'My confidence is high': Longview man treated for prostate cancer urges early screenings - Longview News-Journal Longview’s Jim Hugman is aiming to be part of the 96%. That’s the percentage of men in the state with prostate cancer who survive for at least five years past […]

September is Ovarian Cancer Awareness Month—a perfect time to recognize the specialized care available to women in East Texas with Texas Oncology.

Gynecologic cancers require the expertise of gynecologic oncologists. We are fortunate to have three caring and highly skilled gynecologic oncologists at Texas Oncology Longview Cancer Center, offering advanced surgical care, innovative treatments, and access to an extensive clinical-trial network.

For more than 20+ years, Texas Oncology has provided gynecologic oncology care to East Texas. Backed by Texas Oncology’s 40-year history and more than 600 cancer specialists statewide, our commitment remains the same: experience, research, and compassion—close to home.
@ #
texasoncologylongview www.texasoncology.com Texas Oncology Dr. Chip Hodges Bill Taylor Chip Hodges

Single port mastectomy! The pace of progress in medicine is astounding!

Men: This is a really great set of prostate cancer related questions to ask your primary care doc at your annual appointment.

Some questions are easy to forget until you're already in the room. Screenshot this before your next appointment. 📋

Your annual visit is the perfect time to ask these — don't leave without getting real answers. Texas Urology Specialists and Texas Oncology are here for whatever comes next.

Celebrating an Unsung Cancer Hero! Our Chief Medical Physicist. Jeff turned 30 this week.
“If at first you don’t succeed…try doing what Jeff (quietly and calmly) said to do in the first place.” Happy Birthday Jeff!

During Texas Oncology’s Annual Meeting this past weekend, we celebrated 40 years of serving Texans with cancer.

And in 1993—33 years ago—Texas Oncology Longview began serving the East Texas community as one of the first comprehensive cancer centers built by Texas Oncology.

Today, that mission has grown exponentially, with more than 84 comprehensive cancer centers and 600+ oncologists across the state.

What was clear throughout the meeting is that patients remain at the center of everything we do. The size and scale of our group allow patients—even in communities like East Texas—to have access to cutting-edge technology, innovative treatments, and one of the nation’s largest community-based clinical trial networks.

A central theme throughout the meeting was: How will AI change cancer care?

We heard perspectives from thought leaders from across the country and beyond about how rapidly medicine is evolving and what that could mean for our patients.

I left hopeful about where cancer care is headed and energized about what the next chapter of medicine may bring.

Forty years of Texas Oncology.
Thirty-three years in Longview.
And the most exciting advances in cancer care are still ahead of us. Experience matters when so much is at stake.

A room full of oncologists giving a standing ovation to a clinical trial result—one that offers new hope to a group of patients who previously had few options—is something you may witness only once or twice in an entire career.

The scientists and institutions who funded the research. The pharmaceutical teams who pushed it through the system. The clinical investigators who refused to give up. And most importantly, the patients who trusted the process and courageously signed up for the trial.

They are all heroes.

This is the kind of front-page news that is truly refreshing to see.

Daraxonrasib FDA Approval: How SCRI Helped Advance Therapy for Patients with Pancreatic Cancer SCRI researchers played a role in the development of daraxonrasib,first in class targeted therapy for metastatic pancreatic cancer.

It is easy to get stuck or stop when things get tough.

Keep moving.

Trycja’s story is a great example of resilience!

This is really great advice on how to show up for loved ones and how to be there through the hard patches!

Exciting new FDA approval for men with metastatic hormone sensitive prostate cancer!

Texas Oncology Longview Cancer is the only East Texas Cancer Center offering this treatment!
Dr. Chip Hodges